Trial Outcomes & Findings for The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients (NCT NCT02707770)
NCT ID: NCT02707770
Last Updated: 2021-03-30
Results Overview
6 Minute Walk Test (6MWT)- Distance in meters
TERMINATED
NA
20 participants
0, 8weeks
2021-03-30
Participant Flow
Participant milestones
| Measure |
Ambulatory Oxygen
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)
Pulmonary Rehabilitation
|
Room Air
Patient will breath on room air during pulmonary rehabilitation programme
Pulmonary Rehabilitation
|
|---|---|---|
|
Overall Study
STARTED
|
10
|
10
|
|
Overall Study
COMPLETED
|
9
|
10
|
|
Overall Study
NOT COMPLETED
|
1
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)
|
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme
|
Total
n=19 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
73 years
n=9 Participants
|
72 years
n=10 Participants
|
72.5 years
n=19 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=9 Participants
|
6 Participants
n=10 Participants
|
8 Participants
n=19 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=9 Participants
|
4 Participants
n=10 Participants
|
11 Participants
n=19 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United Kingdom
|
9 participants
n=9 Participants
|
10 participants
n=10 Participants
|
19 participants
n=19 Participants
|
PRIMARY outcome
Timeframe: 0, 8weeks6 Minute Walk Test (6MWT)- Distance in meters
Outcome measures
| Measure |
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)
Pulmonary Rehabilitation
|
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme
Pulmonary Rehabilitation
|
|---|---|---|
|
Change in Functional Exercise Capacity
Baseline -0
|
332 meters
Interval 170.0 to 430.0
|
335 meters
Interval 140.0 to 500.0
|
|
Change in Functional Exercise Capacity
Post PR - 8weeks
|
346 meters
Interval 200.0 to 430.0
|
340 meters
Interval 140.0 to 510.0
|
SECONDARY outcome
Timeframe: 0,8weeksChronic Respiratory Questionnaire(CRQ)- Number of Participants achieving minimal clinically important difference (MCID) in CRQ compared between baseline and follow up assessment.
Outcome measures
| Measure |
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)
Pulmonary Rehabilitation
|
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme
Pulmonary Rehabilitation
|
|---|---|---|
|
Number of Participants Reporting a Change in the Quality of Life
|
3 participants
|
2 participants
|
SECONDARY outcome
Timeframe: 0,8weeksHospital anxiety and depression score- Anxiety component (HADS-A)-Numbers of participants achieving Minimal clinically important difference in HADS-A compared between baseline and follow up assessment.
Outcome measures
| Measure |
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)
Pulmonary Rehabilitation
|
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme
Pulmonary Rehabilitation
|
|---|---|---|
|
Number of Participants Reporting a Change in Anxiety Score
|
4 participants
|
3 participants
|
SECONDARY outcome
Timeframe: 0,8weeksHospital anxiety and depression score- Depression component (HADS-D)-Numbers of participants achieving Minimal clinically important difference in HADS-D compared between baseline and follow up assessment.
Outcome measures
| Measure |
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)
Pulmonary Rehabilitation
|
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme
Pulmonary Rehabilitation
|
|---|---|---|
|
Number of Participants Reporting Change in Depression Score
|
2 participants
|
2 participants
|
SECONDARY outcome
Timeframe: 0,8weeksChronic Obstructive Pulmonary diseases Assessment Test (CAT score)-Numbers of participants achieving Minimal clinically important difference in CAT score compared between baseline and follow up assessment.
Outcome measures
| Measure |
Ambulatory Oxygen
n=9 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)
Pulmonary Rehabilitation
|
Room Air
n=10 Participants
Patient will breath on room air during pulmonary rehabilitation programme
Pulmonary Rehabilitation
|
|---|---|---|
|
Number of Participants Reporting Change in Chronic Obstructive Pulmonary Diseases Assessment Test (CAT)
|
5 participants
|
3 participants
|
SECONDARY outcome
Timeframe: 8 weeksPopulation: Due to technical problems identified with accuracy of device, this outcome measure was excluded from study
Pedometer- Number of step counts
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 0,8 weeksHandheld Muscle testing- Number of participants achieving Minimal clinical important difference in quadriceps muscle strength compared between baseline and follow up assessment
Outcome measures
| Measure |
Ambulatory Oxygen
n=8 Participants
Patient will use ambulatory oxygen during pulmonary rehabilitation programme (flow rate determined at the initial assessment to a maximum flow rate of 6 litres per minute)
Pulmonary Rehabilitation
|
Room Air
n=6 Participants
Patient will breath on room air during pulmonary rehabilitation programme
Pulmonary Rehabilitation
|
|---|---|---|
|
Number of Participants With Change in Quadriceps Muscle Strength
|
0 Participants
|
0 Participants
|
Adverse Events
Ambulatory Oxygen
Room Air
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place